F279-0129 Screening compound: N-(4-chlorophenyl)-2-[4-(3-methoxyphenyl)-3-methyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl]acetamide

F279-0129 Screening compound: N-(4-chlorophenyl)-2-[4-(3-methoxyphenyl)-3-methyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl]acetamide
F279-0129 Screening compound: N-(4-chlorophenyl)-2-[4-(3-methoxyphenyl)-3-methyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F279-0129
N-(4-chlorophenyl)-2-[4-(3-methoxyphenyl)-3-methyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F279-0129

Molecular Formula

C21H17ClN4O4 (C21 H17 ClN4 O4)

Compound Name

N-(4-chlorophenyl)-2-[4-(3-methoxyphenyl)-3-methyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl]acetamide

IUPAC name

N-(4-chlorophenyl)-2-[4-(3-methoxyphenyl)-3-methyl-7-oxo-6H7H-[12]oxazolo[34-d]pyridazin-6-yl]acetamide

SMILES

Cc(onc12)c2C(c2cc(OC)ccc2)=NN(CC(Nc(cc2)ccc2Cl)=O)C1=O

InChI

InChI=1S/C21H17ClN4O4/c1-12-18-19(13-4-3-5-16(10-13)29-2)24-26(21(28)20(18)25-30-12)11-17(27)23-15-8-6-14(22)7-9-15/h3-10H,11H2,1-2H3,(H,23,27)

InChI Key

USDAGKXVQIDHFM-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27111294

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

424.84

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.511

Distribution Coefficient, logD

3.511

Water Solubility, LogSw

-4.43

Polar Surface Area

80.211

Acid Dissociation Constant (pKa)

11.41

Base Dissociation Constant (pKb)

1.33

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

14.30

F279-0129 in Drug Discovery

Included in Screening Libraries

GABA Library (7115 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Eye
Targets:
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F279-0129 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F279-0129?
Check Price and Availability of F279-0129, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F279-0129 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F279-0129
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F279-0129
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F279-0129 available by request